MacroGenics | MGNX - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
AbbVie USD 64.53B 5.59B 2026-03
Amgen USD 51.89B 1.88B 2026-03
AstraZeneca USD 26.01B 46M 2026-06
Biogen USD 7.29B 1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Daiichi Sankyo JPY 500B 199.92B 2026-06
Eli Lilly USD 39.37B 1.5B 2026-03
Genmab DKK 5.14B 5.01B 2025-12
Geron USD 119.83M 286K 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
J&J USD 37.34B 183M 2026-06
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 68.71M 1.29M 2026-03
Merck USD 46.67B 77M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Xencor USD 82.12M 5.64M 2026-03